Prognosis

• recurrence rate for superficial transitional cell carcinoma of the bladder is high.
  • 70% recurrence rate within 5 years
  • at least one occurence occurs in 80% of patients
• prognostic factors for bladder cancer are:
  • grade of tumour
  • depth of invasion
  • presence or absence of CIS
• non-muscle invasive bladder cancer
  • good prognosis - has a 5-year survival rates of 80-100%
• muscle-invasive bladder cancer
  • 5 year survival rates 30-60%
    
    
• 50% of people diagnosed with bladder cancer in England and Wales survive their disease for ten years or more (2010-11)
  
  
• 53% of people diagnosed with bladder cancer in England and Wales survive their disease for five years or more (2010-11)
  
  
• 72% people diagnosed with bladder cancer in England and Wales survive their disease for one year or more (2010-11)
  
  
• bladder cancer survival is higher in men than women
  
  
• almost three-quarters of men in England with bladder cancer diagnosed aged 15-49 survive their disease for five years or more, compared with more than 4 in 10 men diagnosed aged 80 and over (2009-2013)
  
  
• almost 6 in 10 women in England diagnosed with bladder cancer aged 50-59 survive their disease for five years or more, compared to less than a third of women diagnosed aged 80 and over (2009-2013)
  
  
• when diagnosed at its earliest stage, more than 8 in 10 people with bladder cancer will survive their disease for five years or more, compared with around 1 in 10 people when the disease diagnosed at the latest stage

Prognosis for patients with metastatic urothelial cancer is poor, with only 5-10% of patients living 2 years after diagnosis.

Reference:

• American Cancer Society. Cancer Facts and Figures 2013. Accessed 5/4/15.
• Cancer Research UK (accessed 28/5/19).Bladder Cancer.